Mazumdar-Shaw Kiran
Insider CIK 2034672 · BCAX Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| BCAX Bicara Therapeutics Inc. | A Award deriv | 2026-06-09 | 2026-06-10 | 19,475 | — | $0 | 19,475 | SEC↗ |
| BCAX Bicara Therapeutics Inc. | A Award deriv | 2025-06-09 | 2025-06-10 | 23,746 | — | $0 | 23,746 | SEC↗ |
| BCAX Bicara Therapeutics Inc. | C Conversion deriv | 2024-09-16 | 2024-09-16 | 40,000,000 | — | $0 | 0 | SEC↗ |
| BCAX Bicara Therapeutics Inc. | C Conversion deriv | 2024-09-16 | 2024-09-16 | 4,000,000 | — | $0 | 0 | SEC↗ |
| BCAX Bicara Therapeutics Inc. | C Conversion deriv | 2024-09-16 | 2024-09-16 | 3,000,000 | — | $0 | 0 | SEC↗ |
| BCAX Bicara Therapeutics Inc. | C Conversion deriv | 2024-09-16 | 2024-09-16 | 9,990,144 | — | $0 | 0 | SEC↗ |
| BCAX Bicara Therapeutics Inc. | C Conversion | 2024-09-16 | 2024-09-16 | 324,552 | — | $0 | 324,552 | SEC↗ |
| BCAX Bicara Therapeutics Inc. | C Conversion | 2024-09-16 | 2024-09-16 | 1,080,775 | — | $0 | 1,080,775 | SEC↗ |
| BCAX Bicara Therapeutics Inc. | C Conversion | 2024-09-16 | 2024-09-16 | 4,327,365 | — | $0 | 4,443,122 | SEC↗ |
| BCAX Bicara Therapeutics Inc. | C Conversion | 2024-09-16 | 2024-09-16 | 432,736 | — | $0 | 432,736 | SEC↗ |
| BCAX Bicara Therapeutics Inc. | A Award deriv | 2024-09-12 | 2024-09-16 | 23,746 | — | $0 | 23,746 | SEC↗ |